Drug Costs Will Keep Rising in 2017

April 28, 2015 – Congress is likely to do little or nothing to curtail or rollback prescription price increases that are far outpacing inflation.

Bob Kocher and Bryan Roberts, in a commentary for Fortune magazine, made 10 healthcare predictions for the year ahead. They suggest that Obamacare will change less than Republican rhetoric suggests, insurance premiums will spike due to regulatory uncertainty, more retail pharmacies will close than will open, and – alarmingly – that drug prices will continue to rise uncontrolled.

Despite the recent public shaming of drug makers like Valeant and Mylan, the authors predict that, “While Congress may occasionally hold hearings to put pressure on drug makers, it will not be enough to prevent collusion of the entire drug delivery ecosystem to improve their bottom lines at the expense of the commercial employers funding healthcare.”

Not everyone will be a loser in this scenario. The “ecosystem” – as it has been described – is notoriously stacked against self-funded employers to the benefit of pretty much everyone else involved: “when drug prices go up, everyone who touches the drug, including the drug makers, pharmacy benefit managers, pharmacies, and in some cases, providers, all make more money.”

Patients, for their part, have been “desensitized to super expensive drugs through copay coupons and out of pocket maximums well below the price of their drugs.” And as for congress, the authors are undoubtedly safe in this assumption: “We can’t imagine any new legislation being passed to allow re-importation of drugs from countries with lower prices or to enable Medicare to negotiate prices.”

Read the full article here:

“Why Drug Costs Will Keep Rising in 2017”


40 Grove St, Suite 270 Wellesley, MA 02482

  • LinkedIn - White Circle
  • Facebook - White Circle
  • Twitter - White Circle
  • YouTube - White Circle


© Copyright 2020 Scripta Insights, Inc. 

Scripta™ is neither a pharmacy nor a doctor. The benefit service does not tell you what drug to take and does not participate in the drug selection process. Only your physician can determine the medications that are right for you. These alternative medications are options for less costly drugs that physicians may prescribe in place of the medications you are taking now. Scripta has reviewed your current medications only for the purpose of identifying potential cost savings for you to consider with your physician. Scripta has not analyzed the effectiveness or other therapeutic aspects of these medication alternatives. Accordingly, this report and any other forms of communication received from Scripta are not, nor should they be interpreted as, any form of treatment, drug regimen review, or provision of counseling or consultation by a prescriber, pharmacist or pharmacy. Do not stop taking your medication, change your medication, or start taking a new medication without being directed to do so by your physician and filling the prescription under the oversight of a licensed pharmacist. The alternatives set forth above may not be equivalent to your current medication, may interact adversely with your other medications, may not be indicated in light of your other conditions, may cause different or severe side effects, or may be less effective at treating your condition. Medication prices are approximate based on information provided by your pharmacy benefits manager, insurance plans, and/or employer, and may vary from pharmacy to pharmacy. Check with your insurance plan to obtain a full list of pharmacies where your prescriptions can be filled. All information herein is HIPAA protected, treated as highly confidential, and never shared with your employer.

Scripta™, Scripta Insights™ and The Best Meds at the Best Price® are registered trademarks of Scripta Insights, Inc. The contents of the site are for informational purposes only and not intended as a substitute for professional medical advice, diagnosis, or treatment. We do not recommend or endorse any specific prescription drug or pharmacy that may be mentioned herein. Reliance on any information provided by us, our affiliates, employees or others is solely at your own risk.